SCHEMBL14215519

SCHEMBL14215519

C[C@@H](CS(=O)(=O)Cc1ccccc1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.56
ALDH1A1 P00352 3/20 0.53
HSD17B10 Q99714 2/20 0.53
FPR1 P21462 1/20 0.53
KMT2A Q03164 2/20 0.44
MAPT P10636 1/20 0.44
HTT P42858 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
GAA P10253 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
MMP13 P45452 1/20 0.43
FAAH O00519 1/20 0.42
PRSS1 P07477 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3184198 0.83 HPGD (0.42) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL3184211 0.83 HPGD (0.42) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL4891856 0.83 CA2 (0.49) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL4891863 0.83 CA2 (0.49) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL5864392 0.83 CA2 (0.49) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL5516790 0.83 HPGD (0.54) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL12139978 0.81 HPGD (0.58) HPGDALDH1A1HSD17B10FPR1KMT2A
SCHEMBL6631104 0.80 HPGD (0.54) HPGDALDH1A1HSD17B10FPR1CA1
SCHEMBL6631110 0.80 HPGD (0.54) HPGDALDH1A1HSD17B10FPR1CA1
SCHEMBL3183126 0.80 PTGS2 (0.44) HPGDALDH1A1HSD17B10FPR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative SHIONOGI & CO. LTD. (JP) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative CNR1, CNR2, HRH4 HPGD 1169/4885ALDH1A1 4132/4885HSD17B10 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.